포도막 종양 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 연구개발 활동 증가, 임상시험 수 증가, 글로벌 질병 퇴치를 위한 정부 자금 증가, 안과암 발생률 증가, 의료비 지출 증가에 기인하고 있습니다. 주요 동향으로서는 면역요법의 진보, 표적 요법의 개발, 조기 진단에의 중점화, 임상시험 증가, 치료 어프로치의 혁신 등을 들 수 있습니다.
눈암의 이환율 증가는 향후 수년간 포도막 종양 시장의 확대를 견인할 것으로 예측됩니다. 출발 방법, 환경 노출, 고령화 등의 요인에 기인한다고 생각됩니다.
Cancer Research UK는 영국의 눈암 이환율은 2023-2025년과 2038-2040년 사이에 50% 상승하여 2038년에는 인구 10만명당 연간 평균 3건에 이를 것으로 예측했습니다.
포도막 종양 시장의 주요 기업은 치료 성적을 개선하고 환자에 의해 적응된 옵션을 제공하기 위해 T 세포 수용체(TCR) 치료제와 같은 혁신적인 치료법의 개발에 주력하고 있습니다. T세포 수용체란 T세포의 표면에 있는 단백질로, T세포가 특정 항원을 인식하고 결합하여 면역계가 감염세포와 암세포를 식별하고 공격하는 것을 가능하게 합니다.
영국 기반의 생명 공학 회사 Immunocore는 절제 불가능하거나 전이성 포도막 흑색 종 치료제로 승인된 사상 최초의 TCR 기반 치료제인 KIMMT RAK(tebentafusp-tebn)의 미국 FDA 승인을 받았습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 포도막 종양 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업의 분석
- 세계 포도막 종양 시장 : 성장률 분석
- 세계 포도막 종양 시장 실적 : 규모와 성장, 2019-2024
- 세계 포도막 종양 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 포도막 종양 전체 시장 규모(TAM)
제6장 시장 세분화
- 세계 포도막 종양 시장 : 치료유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 약물
- 치료
- 세계 포도막 종양 시장 : 투여 경로별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 오랄
- 주사제
- 기타 루트 관리
- 세계 포도막 종양 시장 : 유통 채널별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 병원 약국
- 온라인 약국
- 소매 약국
- 세계 포도막 종양 시장 : 약물유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 화학요법제
- 표적 치료제
- 면역요법제
- 세계 포도막 종양 시장 : 치료법별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 방사선치료
- 레이저 요법
- 광선역학요법
제7장 지역별/국가별 분석
- 세계 포도막 종양 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 세계 포도막 종양 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 포도막 종양 시장 : 경쟁 구도
- 포도막 종양 시장 : 기업 프로파일
- Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
- Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- IDEAYA Biosciences Inc. Overview, Products and Services, Strategy and Financial Analysis
- Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업 및 혁신 기업
- AstraZeneca plc
- Novartis AG
- Eli Lilly and Company
- Amgen Inc.
- Regeneron Pharmaceuticals Inc.
- Verastem Oncology Inc.
- Iovance Biotherapeutics Inc.
- Immunocore Holdings PLC
- Aura Biosciences
- Foghorn Therapeutics Inc.
- Syncona Limited
- iOnctura SA
- Linnaeus Therapeutics, Inc.
- Delcath Systems Inc
- Bellicum Pharmaceuticals Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 포도막 종양 시장 2029 : 새로운 기회를 제공하는 국가
- 포도막 종양 시장 2029 : 새로운 기회를 제공하는 부문
- 포도막 종양 시장 2029 : 성장 전략
제36장 부록
SHW
Uveal neoplasms are tumors that develop in the uveal tract of the eye, comprising the iris, ciliary body, and choroid. These tumors can be benign (nevus) or malignant (uveal melanoma), impacting vision and potentially spreading to other parts of the body.
The main treatment options for uveal neoplasms are drugs and therapy. Uveal neoplasm drugs are medications used to treat tumors or cancerous growths in the uveal tract, targeting the iris, ciliary body, and choroid. These drugs are administered through various routes, including oral, injectable, and others, and are distributed through multiple channels, such as hospital pharmacies, online pharmacies, and retail pharmacies.
The uveal neoplasms market research report is one of a series of new reports from The Business Research Company that provides uveal neoplasms market statistics, including the uveal neoplasms industry global market size, regional shares, competitors with the uveal neoplasms market share, detailed uveal neoplasms market segments, market trends, and opportunities, and any further data you may need to thrive in the uveal neoplasms industry. This uveal neoplasms market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The uveal neoplasms market size has grown strongly in recent years. It will grow from $1.08 billion in 2024 to $1.15 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth during the historic period can be attributed to the rising prevalence of uveal neoplasms, increased funding for personalized treatments, the growing elderly population, enhanced awareness and early detection, and the increase in cases of genetic disorders.
The uveal neoplasms market size is expected to see strong growth in the next few years. It will grow to $1.45 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth during the forecast period can be attributed to increasing R&D activities, a growing number of clinical trials, rising government funding for global disease eradication, higher incidences of eye cancer, and increasing healthcare expenditures. Key trends include advancements in immunotherapy, the development of targeted therapies, a greater focus on early diagnosis, an increase in clinical trials, and innovations in therapeutic approaches.
The growing incidence of eye cancer is expected to drive the expansion of the uveal neoplasms market in the coming years. Eye cancer refers to the abnormal growth of cells in the eye, which can occur in various regions such as the retina, iris, or optic nerve. This increase in eye cancer cases may be attributed to factors such as better detection methods, environmental exposures, and an aging population. Uveal neoplasms, particularly uveal melanoma, are a rare type of eye cancer that can spread to other organs, especially the liver, posing significant health risks. For example, Cancer Research UK forecasts that eye cancer incidence rates in the UK will rise by 50% between 2023-2025 and 2038-2040, reaching an average of 3 cases per 100,000 people annually by 2038. This rising incidence is fueling the growth of the uveal neoplasms market.
Key players in the uveal neoplasms market are focusing on the development of innovative therapies, such as T cell receptor (TCR) therapeutics, to improve treatment outcomes and offer more targeted options for patients. T cell receptors are proteins on the surface of T cells that allow them to recognize and bind to specific antigens, enabling the immune system to identify and attack infected or cancerous cells. For example, in January 2022, Immunocore, a UK-based biotechnology company, received US FDA approval for KIMMTRAK (tebentafusp-tebn), the first-ever TCR-based therapy approved for treating unresectable or metastatic uveal melanoma. This groundbreaking therapy binds both to tumor cells and T cells, helping the immune system recognize and target the cancer.
In August 2023, TriSalus Life Sciences, a US-based oncology company, merged with MedTech Acquisition Corporation for an undisclosed amount. This merger aims to strengthen TriSalus' platform, improving treatments for liver and pancreatic cancers, including uveal melanoma with liver metastases. The move is expected to accelerate technology development, drive sales growth, and secure funding for key initiatives through mid-2024. MedTech Acquisition Corporation is a US-based special purpose acquisition company (SPAC) focused on merging with businesses in the medical technology sector.
Major players in the uveal neoplasms market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co. Inc., IDEAYA Biosciences Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, Eli Lilly and Company, Amgen Inc., Regeneron Pharmaceuticals Inc., Verastem Oncology Inc., Iovance Biotherapeutics Inc., Immunocore Holdings PLC, Aura Biosciences, Foghorn Therapeutics Inc., Syncona Limited, iOnctura SA, Linnaeus Therapeutics, Inc., Delcath Systems Inc, and Bellicum Pharmaceuticals Inc.
North America was the largest region in the uveal neoplasms market in 2024. The regions covered in uveal neoplasms report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the uveal neoplasms market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The uveal neoplasms market consists of revenues earned by entities by providing services such as diagnostic services, treatment services, and supportive services. The market value includes the value of related goods sold by the service provider or included within the service offering. The uveal neoplasms market also includes sales of diagnostic equipment, therapies, and pharmaceuticals. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Uveal Neoplasms Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on uveal neoplasms market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for uveal neoplasms ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The uveal neoplasms market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Treatment Type: Drugs; Therapy
- 2) By Route Of Administration: Oral; Injectable; Other Route Administration
- 3) By Distribution Channel: Hospitals Pharmacies; Online Pharmacies; Retail Pharmacies
- Subsegments:
- 1) By Drugs: Chemotherapeutic Agents; Targeted Therapy Drugs; Immunotherapy Drugs
- 2) By Therapy: Radiation Therapy; Laser Therapy; Photodynamic Therapy
- Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd; Merck & Co. Inc.; IDEAYA Biosciences Inc.; Bristol-Myers Squibb Company
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Uveal Neoplasms Market Characteristics
3. Uveal Neoplasms Market Trends And Strategies
4. Uveal Neoplasms Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Uveal Neoplasms Growth Analysis And Strategic Analysis Framework
- 5.1. Global Uveal Neoplasms PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Uveal Neoplasms Market Growth Rate Analysis
- 5.4. Global Uveal Neoplasms Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Uveal Neoplasms Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Uveal Neoplasms Total Addressable Market (TAM)
6. Uveal Neoplasms Market Segmentation
- 6.1. Global Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Drugs
- Therapy
- 6.2. Global Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral
- Injectable
- Other Route Administration
- 6.3. Global Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals Pharmacies
- Online Pharmacies
- Retail Pharmacies
- 6.4. Global Uveal Neoplasms Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Chemotherapeutic Agents
- Targeted Therapy Drugs
- Immunotherapy Drugs
- 6.5. Global Uveal Neoplasms Market, Sub-Segmentation Of Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Radiation Therapy
- Laser Therapy
- Photodynamic Therapy
7. Uveal Neoplasms Market Regional And Country Analysis
- 7.1. Global Uveal Neoplasms Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Uveal Neoplasms Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Uveal Neoplasms Market
- 8.1. Asia-Pacific Uveal Neoplasms Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Uveal Neoplasms Market
- 9.1. China Uveal Neoplasms Market Overview
- 9.2. China Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Uveal Neoplasms Market
- 10.1. India Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Uveal Neoplasms Market
- 11.1. Japan Uveal Neoplasms Market Overview
- 11.2. Japan Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Uveal Neoplasms Market
- 12.1. Australia Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Uveal Neoplasms Market
- 13.1. Indonesia Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Uveal Neoplasms Market
- 14.1. South Korea Uveal Neoplasms Market Overview
- 14.2. South Korea Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Uveal Neoplasms Market
- 15.1. Western Europe Uveal Neoplasms Market Overview
- 15.2. Western Europe Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Uveal Neoplasms Market
- 16.1. UK Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Uveal Neoplasms Market
- 17.1. Germany Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Uveal Neoplasms Market
- 18.1. France Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Uveal Neoplasms Market
- 19.1. Italy Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Uveal Neoplasms Market
- 20.1. Spain Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Uveal Neoplasms Market
- 21.1. Eastern Europe Uveal Neoplasms Market Overview
- 21.2. Eastern Europe Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Uveal Neoplasms Market
- 22.1. Russia Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Uveal Neoplasms Market
- 23.1. North America Uveal Neoplasms Market Overview
- 23.2. North America Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Uveal Neoplasms Market
- 24.1. USA Uveal Neoplasms Market Overview
- 24.2. USA Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Uveal Neoplasms Market
- 25.1. Canada Uveal Neoplasms Market Overview
- 25.2. Canada Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Uveal Neoplasms Market
- 26.1. South America Uveal Neoplasms Market Overview
- 26.2. South America Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Uveal Neoplasms Market
- 27.1. Brazil Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Uveal Neoplasms Market
- 28.1. Middle East Uveal Neoplasms Market Overview
- 28.2. Middle East Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Uveal Neoplasms Market
- 29.1. Africa Uveal Neoplasms Market Overview
- 29.2. Africa Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Uveal Neoplasms Market Competitive Landscape And Company Profiles
- 30.1. Uveal Neoplasms Market Competitive Landscape
- 30.2. Uveal Neoplasms Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. IDEAYA Biosciences Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
31. Uveal Neoplasms Market Other Major And Innovative Companies
- 31.1. AstraZeneca plc
- 31.2. Novartis AG
- 31.3. Eli Lilly and Company
- 31.4. Amgen Inc.
- 31.5. Regeneron Pharmaceuticals Inc.
- 31.6. Verastem Oncology Inc.
- 31.7. Iovance Biotherapeutics Inc.
- 31.8. Immunocore Holdings PLC
- 31.9. Aura Biosciences
- 31.10. Foghorn Therapeutics Inc.
- 31.11. Syncona Limited
- 31.12. iOnctura SA
- 31.13. Linnaeus Therapeutics, Inc.
- 31.14. Delcath Systems Inc
- 31.15. Bellicum Pharmaceuticals Inc.
32. Global Uveal Neoplasms Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Uveal Neoplasms Market
34. Recent Developments In The Uveal Neoplasms Market
35. Uveal Neoplasms Market High Potential Countries, Segments and Strategies
- 35.1 Uveal Neoplasms Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Uveal Neoplasms Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Uveal Neoplasms Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
